VRC 300: Screening of Healthy Volunteers for Clinical Trials of Investigational Vaccines to Prevent Infectious Diseases
Healthy
About this trial
This is an observational trial for Healthy focused on measuring Biodefense, Prevention, Emergent, Virus, Immune Response, Healthy Volunteer, HV
Eligibility Criteria
INCLUSION CRITERIA: Age: 18 to 70 years of age Available to participate for the planned duration of the investigational vaccine study for which the screening is being done (vaccine studies may require 6 months to 18 months of clinic visits). Able and willing to complete the informed consent process. Agree to have blood stored for future studies of the vaccine, the immune system, and/or other medical conditions. EXCLUSION CRITERIA: Known to be infected with HIV, syphilis, tuberculosis, hepatitis B or hepatitis C. A condition in which repeated blood draws or injections pose more than minimal risk for the subject such as hemophilia, other severe coagulation disorders or significantly impaired venous access. A condition that requires active medical intervention or monitoring to avert serious danger to the participant's health or well-being. Known to be pregnant or breast-feeding.
Sites / Locations
- National Institutes of Health Clinical Center, 9000 Rockville Pike
- Clinical Alliance for Research and Education - Infectious Diseases, LLC